Cargando…
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial
BACKGROUND: Juvenile Idiopathic Arthritis (JIA) may cause significant impairment in health-related quality of life (HrQoL), despite effective therapies. The aim of this study was to assess HrQoL during first-year treatment in patients with new-onset polyarticular JIA, and to compare treatment strate...
Autores principales: | Tarkiainen, Maarit, Tynjälä, Pirjo, Vähäsalo, Paula, Kröger, Liisa, Aalto, Kristiina, Lahdenne, Pekka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915981/ https://www.ncbi.nlm.nih.gov/pubmed/31842940 http://dx.doi.org/10.1186/s12969-019-0370-1 |
Ejemplares similares
-
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022) -
Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008) -
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Lahdenne, Pekka, et al.
Publicado: (2018) -
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017) -
Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis
por: Backström, Maria, et al.
Publicado: (2019)